Cargando…
Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
The IgG‐degrading enzyme derived from Streptococcus pyogenes (Imlifidase, Hansa Biopharma) is a novel agent that cleaves all four human subclasses of IgG and has therapeutic potential for HLA desensitization in kidney transplantation and antibody‐mediated rejection. Data from clinical trials in kidn...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293130/ https://www.ncbi.nlm.nih.gov/pubmed/34467625 http://dx.doi.org/10.1111/ajt.16828 |